Hosted on MSN9h
Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn
Bain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.
Paramount Inks 30-Picture Financing Deal With Domain Capital Group
The slate deal locks in the Patrick R. Leardo-run investment group as a key partner for the studio as it looks to transition to Skydance Media ownership this year.
IEQ’s Robert Skinner: What It Took to Build a $35B Firm After Leaving Merrill
Robert Skinner doesn’t want to talk about where he wants IEQ Capital’s assets under management, recently $35 billion, to be in five years. “That’s severely ancillary to” investment performance and ...
Bisnow17h
Bain Names New Head Of Real Estate Capital Markets
Keith Largay joins Bain Capital from JLL, where he spent 14 years and most recently served as co-head of its Chicago office.
Bain to buy Japan's Mitsubishi Tanabe Pharma for $3.4 billion
U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...
Bain Capital buys Japanese pharma for $3.3B
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
alternativeswatch19h
Bain Capital to acquire Japanese pharma giant in $3.3bn deal
Bain Capital entered a deal to acquire Mitsubishi Tanabe Pharma Corporation (MTPC) from Mitsubishi Chemical Group for 510 ...
Turn/River Capital to take SolarWinds private in $4.4 billion deal
SolarWinds said on Friday it would go private in a $4.4 billion deal with buyout firm Turn/River Capital, the latest sign debt-funded deals were set to rebound this year as borrowing costs decline.
BioPharma Dive20h
Bain buys Mitsubishi pharma unit; Bausch + Lomb deal talks come up empty
The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...